Impact of overweightness and critical weight loss on overall survival in patients with hepatocellular carcinoma initially treated with chemoembolization.
Zhen-Xin ChenZhi-Wei JianXi-Wen WuJun-Cheng WangJing-Yuan PengChun-Yu HuangXiang-Ming LaoPublished in: Gastroenterology report (2019)
Among patients with intermediate- or advanced-stage HCC initially treated with chemoembolization, overweightness was associated with longer OS. Furthermore, CWL was an independent adverse prognostic factor for OS in patients receiving additional treatment.